Is Okta a Good Stock to Buy?
Okta (NASDAQ:OKTA) is used by some of the largest firms…
Sell
39
CVS Quote, Financials, Valuation and Earnings
Last price:
$63.70
Seasonality move
:
1.48%
Day range:
$63.50 - $66.98
52-week range:
$43.56 - $75.12
Dividend yield:
4.18%
P/E ratio:
17.39x
P/S ratio:
0.22x
P/B ratio:
1.06x
Volume:
13.3M
Avg. volume:
8.7M
1-year change:
-13.86%
Market cap:
$80.3B
Revenue:
$372.8B
EPS (TTM):
$3.66
Earnings Data
Next earnings date for CVS
May 01
2025
Most recent earnings per share
$1.30
Beat by $0.38
(Feb 12/2025)
Consensus Estimate
$0.92
(Feb 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CVS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $95.2B | -- | -- | $1.58 | -- |
| 05/01/2025 | Q1 | $93.1B | -- | -- | $1.62 | -- |
| 02/12/2025 | Q4 | $96.9B | $97.7B | $1.30 | $0.92 | $0.38 |
| 11/06/2024 | Q3 | $92.7B | $95.4B | $0.07 | $1.45 | -$1.38 |
| 08/07/2024 | Q2 | $91.4B | $91.2B | $1.41 | $1.73 | -$0.32 |
| 05/01/2024 | Q1 | $89.2B | $88.4B | $0.88 | $1.70 | -$0.82 |
| 02/07/2024 | Q4 | $90.7B | $93.8B | $1.58 | $1.99 | -$0.41 |
| 11/01/2023 | Q3 | -- | -- | $1.75 | $2.13 | -$0.38 |
| 08/02/2023 | Q2 | -- | -- | $1.48 | $2.12 | -$0.64 |
| 05/03/2023 | Q1 | -- | -- | $1.65 | $2.09 | -$0.44 |
| 02/08/2023 | Q4 | -- | -- | $1.75 | $1.93 | -$0.18 |
| 11/02/2022 | Q3 | -- | -- | -$2.60 | $1.99 | -$4.59 |
| 08/03/2022 | Q2 | -- | -- | $2.23 | $2.18 | $0.05 |
| 05/04/2022 | Q1 | -- | -- | $1.74 | $2.15 | -$0.41 |
| 02/09/2022 | Q4 | -- | -- | $0.98 | $1.88 | -$0.90 |
| 11/03/2021 | Q3 | -- | -- | $1.20 | $1.79 | -$0.59 |
| 08/04/2021 | Q2 | -- | -- | $2.10 | $2.07 | $0.03 |
| 05/04/2021 | Q1 | -- | -- | $1.68 | $1.77 | -$0.09 |
| 02/16/2021 | Q4 | -- | -- | $0.74 | $1.24 | -$0.50 |
| 11/06/2020 | Q3 | -- | -- | $0.93 | $1.34 | -$0.41 |
| 08/05/2020 | Q2 | -- | -- | $2.26 | $1.92 | $0.34 |
| 05/06/2020 | Q1 | -- | -- | $1.53 | $1.63 | -$0.10 |
| 02/12/2020 | Q4 | -- | -- | $1.33 | $1.69 | -$0.36 |
| 11/06/2019 | Q3 | -- | -- | $1.17 | $1.77 | -$0.60 |
| 08/07/2019 | Q2 | -- | -- | $1.49 | $1.69 | -$0.20 |
| 05/01/2019 | Q1 | -- | -- | $1.09 | $1.51 | -$0.42 |
| 02/20/2019 | Q4 | -- | -- | -$0.37 | -- | -- |
| 11/06/2018 | Q3 | -- | -- | $1.36 | -- | -- |
| 08/08/2018 | Q2 | -- | -- | -$2.52 | -- | -- |
| 05/02/2018 | Q1 | -- | -- | $0.98 | -- | -- |
| 02/08/2018 | Q4 | -- | -- | $3.22 | -- | -- |
| 11/06/2017 | Q3 | -- | -- | $1.26 | -- | -- |
| 08/08/2017 | Q2 | -- | -- | $1.07 | -- | -- |
| 05/02/2017 | Q1 | -- | -- | $0.92 | -- | -- |
| 02/09/2017 | Q4 | -- | -- | $1.59 | -- | -- |
| 11/08/2016 | Q3 | -- | -- | $1.43 | -- | -- |
| 08/02/2016 | Q2 | -- | -- | $0.86 | -- | -- |
| 05/02/2016 | Q1 | -- | -- | $1.04 | -- | -- |
| 02/09/2016 | Q4 | -- | -- | $1.34 | -- | -- |
| 10/30/2015 | Q3 | -- | -- | $1.11 | -- | -- |
| 08/04/2015 | Q2 | -- | -- | $1.12 | -- | -- |
CVS Health Earnings Questions
-
How Much did CVS Health Generate in Revenue Last Quarter?
CVS Health reported $97.7B worth of top line sales in its most recent quarter.
-
Did CVS Health Beat Earnings Last Quarter?
CVS Health announced earnings per share of $1.30 which represents a beat of analyst forecast a $0.92 per share.
-
Is CVS Health Profitable?
CVS Health reported $12.9B that represents $10.22 per share over the last quarter.
-
What is the Analyst Consensus for CVS Health EPS Next Year?
CVS Health's earnings are forecast to grow from $3.66 per share to $5.18 per share next year representing an increase of 61.29%.
-
When is CVS Health's Earnings Date?
CVS Health's next earnings date is May 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Fidelity High Dividend ETF a Good Investment Now?
Fidelity’s High Dividend ETF (FDVV) is a fund that offers…
Is Kinder Morgan Dividend Yield Worth It?
Kinder Morgan (NYSE:KMI) is a major energy infrastructure company in…
Stock Ideas
Sell
37
Is AAPL Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 31x
Sell
37
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
31
Is NVDA Stock a Buy?
Market Cap: $2.3T
P/E Ratio: 32x
Alerts
Sell
45
RGC alert for Apr 5
Regencell Bioscience Holdings [RGC] is up 32.59% over the past day.
Sell
25
GDXU alert for Apr 5
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 27.33% over the past day.
Buy
76
SOXS alert for Apr 5
Direxion Daily Semiconductor Bear 3X Shares [SOXS] is up 23.96% over the past day.
